New post-liver transplant protocol results in 0% heavy alcohol relapse rate

In a study published in the Liver Transplantation journal, Mayo Clinic researchers have found that a new proactive treatment ...
ascopubs.org

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D and doxorubicin. A report from the National Wilms Tumor Study (NWTS) Group

NWTS - 5 was a multi-institutional clinical trial for patients less than 16 years of age at diagnosis with specific renal neoplasms who were diagnosed between August 1, 1995 and May 31, 2002. A ...
The New England Journal of Medicine

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

The prognosis of patients with early relapsed or refractory large B-cell lymphoma after the receipt of first-line chemoimmunotherapy is poor. In this international, phase 3 trial, we randomly assigned ...
ascopubs.org

Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report This ...
Nasdaq

Syndax Announces Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia Meets Primary Endpoint and Stopped Early for Efficacy Following Protocol ...

– Trial met its primary endpoint with a CR/CRh rate of 23% at interim analysis of the pooled KMT2Ar AML and ALL cohorts (p-value = 0.0036); an additional 14% of patients proceeded to transplant ...
Healthline

What Happens If You Have an ALL Relapse?

As with many types of cancer, acute lymphoblastic leukemia (ALL), also known as acute lymphocytic leukemia, can come back after successful treatment. This is known as a relapse. Relapses can cause you ...
Science Daily

New personalized test for an earlier and more accurate prediction of cancer relapse

Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia (ALL), the most common cancer in children, to inform more effective treatment strategies and detect disease ...